CClinicalTrials.gg
CompletedNCT01943227Updated Oct 28, 2019Results posted

Effect of Alveolar Minute Ventilation on Respiratory Gas Heat Content

An observational study in Ventilation Perfusion Mismatch, sponsored by University of California, Davis. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-10-28.

Sponsored by University of California, Davis · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

This is a single site, prospective, non-blinded, non-randomized, non-interventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy).

Read the detailed description

This is a single site, prospective, non-blinded, non-randomized, noninterventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy). Each patient will serve as their own control. The study will enroll adult patients without cardiac or respiratory illness. It is designed to evaluate the effect of the ventilatory pattern (tidal volume, rate) on respiratory heat loss measured using the VQm™ monitor during standard intra-operative clinical care that requires positive pressure ventilation (PPV)

02

Conditions studied

  • Ventilation Perfusion Mismatch

Keywords

  • humidity
  • enthalpy
  • mechanical ventilation
03

In context

Lead sponsor

University of California, Davis is the lead sponsor of 798 studies on the registry; 146 are open to participants now.

Of its 65 completed or terminated interventional studies of FDA-regulated products, 43 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

adult patients without cardiac or respiratory illness

Inclusion criteria

  • age greater than 18 years
  • scheduled for an elective surgical procedure with an anticipated duration of more than 2 hours requiring general anesthesia and positive pressure ventilation using an endotracheal tube
  • patient status ASA 1, 2 or 3
  • no significant cardio-vascular or respiratory disease
  • supine surgical position

Exclusion criteria

Exclusion Criteria:

  • Adults unable to give primary consent
  • age less than 18 years
  • pregnancy
  • prisoners
  • pre-existing cardiac or pulmonary disease
  • infusion of inotropic drugs
  • positive end expiratory pressure (PEEP) requirements >8 cm H2O
  • increased intra-abdominal pressure (e.g. planned surgical pneumoperitoneum or ascitis)
  • intra-operative patient position other than supine
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • 6ml/kg

    Enthalpy measured in patients receiving controlled positive pressure ventilation 6ml/kg Tidal volume. The VQm monitor samples the gas at a rate of 3 L/min, returning the analyzed gas to the circuit. As the exhaled gas passes through the analytical chamber, the temperature and humidity are measured essentially continuously (40Hz). These data are combined with pressure measurements to determine the exhaled gas volume and then the heat content (enthalpy) is calculated.

    Other: controlled positive pressure ventilation 6ml/kg tidal volume

  • 9ml/kg

    Enthalpy measured in patients receiving controlled positive pressure ventilation 9ml/kg Tidal volume. The VQm monitor samples the gas at a rate of 3 L/min, returning the analyzed gas to the circuit. As the exhaled gas passes through the analytical chamber, the temperature and humidity are measured essentially continuously (40Hz). These data are combined with pressure measurements to determine the exhaled gas volume and then the heat content (enthalpy) is calculated.

    Other: controlled positive pressure ventilation 9ml/kg tidal volume

Interventions

  • Othercontrolled positive pressure ventilation 9ml/kg tidal volume

    controlled positive pressure ventilation 9ml/kg tidal volume

  • Othercontrolled positive pressure ventilation 6ml/kg tidal volume

    controlled positive pressure ventilation 6ml/kg tidal volume

06

What researchers measure

Primary outcomes

  1. Airway Enthalpy

    This is a single site, prospective, non-blinded, non-randomized, non-interventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy) in Joules per minute.

    Time frame: 12 months

07

Results

Posted Oct 28, 2019

Participant flow

Patient recruitment and informed consent will be obtained in the UCDMC perioperative suite. Recruitment will be by direct discussion between the prospective candidates and the study investigators prior to their scheduled surgical procedure. The investigators will provide the consent form in person and give subject time to discuss with family.

Participant flow — Overall Study
MilestoneLarge Tidal VolumeSmal Tidal Volume
Started1010
Completed1010
Not completed00

Outcome measures

PrimaryAirway Enthalpy

This is a single site, prospective, non-blinded, non-randomized, non-interventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy) in Joules per minute.

Time frame:
12 months
Reported as:
Mean · Joules/Minute
Airway Enthalpy
Joules/MinuteLarge Tidal VolumeSmal Tidal Volume
Airway Enthalpy32 ± 9.123 ± 8.9

Adverse events

Collected over 24 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Large Tidal Volume0/10 (0%)0/10 (0%)0/10 (0%)
Small Tidal Volume0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

The study will enroll adult patients without cardiac or respiratory illness.

Age, Categorical
Age, Categorical(Participants)Large Tidal VolumeSmall Tidal VolumeTotal
<=18 years000
Between 18 and 65 years101020
>=65 years000
Age, Continuous
Age, Continuous(Years)Large Tidal VolumeSmall Tidal VolumeTotal
Mean44 ± 10.842 ± 13.843 ± 12.5
Sex: Female, Male
Sex: Female, Male(Participants)Large Tidal VolumeSmall Tidal VolumeTotal
Female639
Male4711
Region of Enrollment
Region of Enrollment(participants)Large Tidal VolumeSmall Tidal VolumeTotal
United States101020
08

Study locations

1 site
  • UC Davis Health System
    Sacramento, California 95817, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01943227
Lead sponsor
University of California, Davis
Responsible party
Sponsor
First posted
Sep 16, 2013
Start date
Aug 2013
Primary completion
Mar 2014
Completion
Mar 2014
Results posted
Oct 28, 2019
Last update
Oct 28, 2019

Study contacts

Neal Fleming, MD, PhD
principal investigator · Professor, Anesthesiology & Pain Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion